Position in SCLX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$31
+$5 QoQ
Shares Held
4
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 23 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PFS Partners, LLC holds $1,820,727 across 11 Drug Manufacturers - General names. SCLX ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
4,033 | $518,240 | |
| 2 | ABBV |
AbbVie Inc.
|
1,870 | $470,566 | |
| 3 | LLY |
ELI LILLY & Co
|
321 | $385,017 | |
| 4 | JNJ |
Johnson & Johnson
|
1,319 | $334,986 | |
| 5 | PFE |
Pfizer Inc
|
2,478 | $59,670 | |
| 6 | AMGN |
Amgen Inc
|
44 | $15,933 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
95 | $12,002 | |
| 8 | AZN |
Astrazeneca PLC
|
55 | $10,429 |
All Filings in SCLX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31 | 4 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $26 | 4 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $48 | 4 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $78 | 4 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $23 | 4 | Shares | Sole | 2025-07-16 | |
| No filing history on record for this holder in this stock. | ||||||